Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan

Anila Rashid; Zurrya Khan; Junaid Alam

doi:10.1080/00365513.2022.2092902

Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan

Anila Rashid, Zurrya Khan, Junaid Alam

Department of Pathology and Laboratory Medicine, Medical College, Pakistan

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English (UK)
Pages (from-to)	432-434
Number of pages	3
Journal	Scandinavian Journal of Clinical and Laboratory Investigation
Volume	82
Issue number	5
DOIs	https://doi.org/10.1080/00365513.2022.2092902
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/00365513.2022.2092902

Cite this

@article{78f121b7160243d88c15fc7223f1a276,

title = "Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan",

author = "Anila Rashid and Zurrya Khan and Junaid Alam",

year = "2022",

doi = "10.1080/00365513.2022.2092902",

language = "English (UK)",

volume = "82",

pages = "432--434",

journal = "Scandinavian Journal of Clinical and Laboratory Investigation",

issn = "0036-5513",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Acquired hemophilia A with SARS-CoV-2 mRNA vaccine

T2 - first case from Pakistan

AU - Rashid, Anila

AU - Khan, Zurrya

AU - Alam, Junaid

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85133290901

U2 - 10.1080/00365513.2022.2092902

DO - 10.1080/00365513.2022.2092902

M3 - Letter

C2 - 35767232

AN - SCOPUS:85133290901

SN - 0036-5513

VL - 82

SP - 432

EP - 434

JO - Scandinavian Journal of Clinical and Laboratory Investigation

JF - Scandinavian Journal of Clinical and Laboratory Investigation

IS - 5

ER -

Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan

UN SDGs

Access to Document

Other files and links

Cite this